4//SEC Filing
Tyagarajan Seshu 4
Accession 0000950170-25-006733
CIK 0001841387other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:30 PM ET
Size
5.1 KB
Accession
0000950170-25-006733
Insider Transaction Report
Form 4
Tyagarajan Seshu
Chief Technology Officer
Transactions
- Sale
Common Stock
2025-01-15$7.22/sh−14,322$103,476→ 96,790 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001923794
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:30 PM ET
- Size
- 5.1 KB